SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Non-Tech : GNCI General Nutrition -- Ignore unavailable to you. Want to Upgrade?


To: Roger Bodine who wrote (88)7/5/1999 7:47:00 PM
From: Roger Bodine  Respond to of 110
 



Headlines from Reuters


07/05 10:31 NUMICO<NUMCc.AS> SAYS TO MAKE
PUBLIC $25/SHR BID FOR U.S.
GENERAL NUTRITION CO

AMSTERDAM, July 5 (Reuters) - Dutch food group Numico NV said on
Monday it planned to make a friendly bid for U.S. food supplement maker
and retailer General Nutrition Cos Inc.

The $25 per share bid is worth $1.77 billion and Numico will also take over
$760 million in debt, making the total transaction worth $2.5 billion, Numico
said in a statement.

The takeover will be financed through bank loans, and by issuing both
Numico shares and subordinated convertible bonds at a later date, the Dutch
group added.

COPYRIGHT © 1999 REUTERS LIMITED. ALL RIGHTS RESERVED.



To: Roger Bodine who wrote (88)7/5/1999 7:52:00 PM
From: Roger Bodine  Respond to of 110
 
07/05 11:02 General Nutrition in Merger Agreement
with Royal Numico <GNCI.O>

General Nutrition in Merger Agreement with Royal Numico

$2.5 Billion Transaction to Create a Global Leader in Human Nutrition

Dutch Company Accesses High-Growth U.S. Supplements Market;

GNC Gains Access To Major Nutrition Research Capabilities

ZOETERMEER, The Netherlands and PITTSBURGH, July 5 /PRNewswire/ --
Royal Numico N.V. (Amsterdam Stock Exchange: NUTV), a leading
European manufacturer and marketer of specialized nutrition products, and
General Nutrition Companies, Inc. (Nasdaq: GNCI), a leading manufacturer
and retailer of nutritional supplements in the U.S., today announced they
have signed a definitive merger agreement that will create a global leader in
human nutrition. Under the terms of the agreement, Numico will make a $25
per share cash tender offer for all of GNC's approximately 75 million
outstanding shares and options and will assume $760 million in debt, valuing
the transaction at approximately $2.5 billion.

The combined company would have pro forma sales of approximately US$3.0
billion, based on the fiscal 1998 financial statements of Numico and GNC,
and will have nearly 27,000 employees worldwide. Numico expects the
merger to result in significant incremental revenue from new product
development and, based on currently available information, believes the
transaction will be immediately accretive to earnings.

In a joint statement, J.C.T. van der Wielen, President and CEO of Numico,
and William E. Watts, President and CEO of GNC, said, "This merger
creates the largest company in the world exclusively devoted to human
nutrition. It enhances GNC's current leading position in the U.S. nutritional
supplements segment and positions Numico to be a leader in the worldwide
supplements market -- a market where proprietary research coupled with
marketing and branding expertise will determine category leadership."

The two executives cited several other complementary strengths of the
combined companies:

-- Numico's leadership in clinical research on human nutrition reinforces

GNC's focus on science-based consumer products as a key market

differentiator.

-- GNC's proven ability to develop and market branded product in the U.S.

offers crossover potential for Numico's existing lines of supplements

in Europe.

-- Numico's global view of the nutrition business will accelerate GNC's

evolution into an international marketer of nutrition products.

-- GNC's leading role in nutrition marketing in the U.S. complements

Numico's strong market presence and distribution in Europe and Asia.

Mr. van der Wielen said, "The U.S. has long represented a significant
opportunity for Numico, but we wanted to enter this market with a partner
who could give us critical mass in marketing, manufacturing and branding.
GNC is the solution to our needs. They have the largest manufacturing
facility for supplements in the U.S. The GNC brand has broad awareness,
credibility and acceptance with a wide range of American consumers. And,
they are a leader in the specialty retail channel in the U.S. for vitamins and
other nutritional supplements. We are very pleased with this transaction.

"Moving forward," he added, "Numico is committed to maintaining and
expanding GNC's existing business, including its successful use of
franchising. Also, we look to fully utilize GNC's expanded manufacturing
capabilities in South Carolina."

Mr. Watts said, "We strongly believe the merger is in the best interests of
GNC shareholders. It also reflects an exciting new phase in the evolution of
our company. GNC already has a leading market share in the U.S.
supplement segment. Building on our leadership in the specialty retailing
channel, we have created a major strategic alliance with Rite Aid to access
the mass market channel and we have just announced an alliance with
drugstore.com, the leading e-retailing source for health and nutrition
products, to access the fast-growing electronic channel. What this deal does
for GNC is to further enhance our strong position in supplements through
access to world class nutrition research that will result in new proprietary
products.

"This is a strategy-driven merger that allows both parties to take advantage of
the growing global demand for health products," Mr. Watts continued.
"GNC's current management team, which was the engine behind our 21%
compounded annual growth rate in sales between 1993 and 1998, is
committed to working with our new parent to expand GNC's penetration of
nutrition retailing, both in the U.S. and in key international markets."

GNC President and CEO William E. Watts and the senior managers of the
company have entered into employment agreements to remain with Numico
following the merger. Additionally, Mr. Watts is expected to be named to the
Board of Managing Directors of Numico.

The Board of Directors of GNC has unanimously approved the tender offer
and the merger and has recommended that GNC shareholders tender their
shares. Numico will commence a tender offer for GNC shares not later than
July 12, 1999. The tender offer will be conditioned upon the valid tender of a
majority of the GNC shares, on a fully diluted basis, as well as review under
the Hart-Scott-Rodino Act and other customary conditions. Any shares not
acquired in the tender offer will be acquired in a second step merger at the
same price per share. J.P. Morgan & Co. Incorporated will be the
dealer-manager and MacKenzie Partners will be the information agent for the
tender offer. The financial advisor to Numico was J.P. Morgan & Co.
Incorporated, and Morgan Stanley Dean Witter was the advisor to GNC. The
acquisition will be financed through a bridge facility which Numico intends to
refinance, in part, through an equity offering and a subordinated convertible
bond issue aggregating approximately Euro1,050,000,000.

Royal Numico N.V. (www.numico.com), headquartered in Zoetermeer, The
Netherlands, is a holding company of a group of leaders in specialized
nutrition, such as Nutricia, Milupa and Cow & Gate. Numico concentrates on
the development, manufacture and sales of specialized nutrition products,
based upon medical scientific concepts with a high added value. The
company operates in more than 40 countries, including major market centers
in Europe, including Russia; Turkey; and the Pacific Rim, ranging from China
to New Zealand. Numico had net sales of US$1.6 billion, and operating
income of US$238 million for the year ended December 31, 1998.

General Nutrition Companies, Inc. (www.gnc.com), based in Pittsburgh, PA,
is the only nationwide specialty retailer of vitamin and mineral supplements,
sports nutrition and herbal products and is also a leading provider of personal
care, fitness and other health related products. The company's products are
sold through a network of 4,203 retail stores operating under the General
Nutrition Centers, Health & Diet Center and GNC Live Well names, of which
2,726 are company-owned and 1,477 are franchised. The Company's stores
are located in all 50 States, Puerto Rico and 25 foreign markets. For the
fiscal year ended February 6, 1999, GNC had net revenue of $1.42 billion,
and net earnings of approximately $91.0 million. GNC + Numico 'Global
Leadership'

-- This merger creates the largest company in the world exclusively

devoted to human nutrition. -- This deal enhances GNC's current leading
position in nutritional

supplements in the U.S. and perfectly positions Numico to be a leader

in the global supplements market -- a market where proprietary research

coupled with marketing and branding expertise will determine the

category killer.

The Companies

General Nutrition Royal Numico

Largest specialty retailer of Leading manufacturer of specialized

nutritional supplements in U.S. nutrition products. Operations in

-- 4,203 stores in all 50 states more than 40 countries.

and 25 foreign markets.

Fiscal 1998 net revenues 1998 net sales - $1.6 billion.

-- $1.42 billion.

Estimated 13% of domestic share Leading share of specialized

in supplements segment. nutrition products for children and

people with special nutrition needs

-- also nutriceuticals and

dairy-based consumer products

Largest manufacturer of Manufacturing facilities in more than

supplements in U.S. 50 countries around the world;

(Greenville, S.C. plant). research facilities in The

Netherlands, Germany, the U.K. and

Australia.

Headquartered in Pittsburgh, Pa.; Headquartered in Zoetermeer, The

COPYRIGHT © 1999 REUTERS LIMITED. ALL RIGHTS RESERVED.



To: Roger Bodine who wrote (88)7/5/1999 7:56:00 PM
From: Roger Bodine  Respond to of 110
 
07/05 12:53 FOCUS-Dutch Numico to
buy U.S. GNC for $2.5 bln

(adds background, quotes, recasts) By Eric Onstad

AMSTERDAM, July 5 (Reuters) - Dutch food group Numico NV
<NUMCc.AS> said on Monday it would buy U.S. food supplement maker
and retailer General Nutrition Cos Inc. (GNC) <GNCI.O> for $2.5 billion.

The friendly takeover would create a food supplements giant with sales of
about $3.0 billion and a workforce of about 27,000, Numico said.

"This is a strategy-driven merger that allows both parties to take advantage of
the growing global demand for health products," GNC President William
Watts said in a statement.

Numico's strength in clinical research and GNC's U.S. food supplements
market share of 13 percent are a good match, the firms said.

The combined company should be able to boost sales by 600 million guilders
($278.6 million) within three years and the deal will immediately bolster
earnings per share, they added.

Numico, whose core product has been baby food, said a number of new
products it was developing would now be able to be widely distributed without
extra marketing costs.

The $25 per share bid -- a 31 percent premium over GNC's 30-day average --
is worth $1.77 billion. Numico will also assume $760 million in debt, making
the total transaction worth $2.5 billion.

GNC, with a 1998 turnover of about $1.42 billion, sells its products in 4,203
specialty shops in all 50 U.S. states and in 25 foreign markets.

The U.S. food supplement sector is growing at 14 percent per year with total
1998 sales of $8.9 billion expected to rise to $16.6 billion in 2003, Numico
said.

About 45 percent of Americans take vitamins.

GNC has recently agreed on an alliance with U.S. mass market retailer Rite
Aid and another with drugstore.com, the leading Internet seller of health and
nutrition products.

Watts and other GNC senior managers have decided to remain with Numico
and Watts is due to join the executive board.

The takeover will initially be financed through bridging bank loans, and later
partly refinanced by issuing both Numico shares and subordinated
convertible bonds worth a total of about 1.05 billion euros. ((Amsterdam
newsroom +31 20 504 5000, Fax +31 20 504 5040
amsterdam.newsroom@reuters.com))

COPYRIGHT © 1999 REUTERS LIMITED. ALL RIGHTS RESERVED.



To: Roger Bodine who wrote (88)7/5/1999 7:59:00 PM
From: Roger Bodine  Read Replies (1) | Respond to of 110
 
Headlines from Reuters


07/05 17:20 INTERVIEW-Royal Numico
buys GNC

By Ilaina Jonas

NEW YORK, July 5 (Reuters) - Over the past 75 years General Nutrition
Companies Inc. <GNCI.O> has become the leader in the U.S. market for
vitamins and nutritional supplements by manufacturing and distributing
products developed by outside research companies.

Across the Atlantic, Dutch company, Royal Numico N.V.'s research facilities
have developed and manufactured infant nutritional products, of which it has a
40 percent market share in Europe. It also produces clinical nutritional
supplements for people fighting illnesses and within the past year has
acquired a small interest in producing vitamins and minerals.

On Monday, the companies said Numico would buy GNC for $25 per share,
or $1.77 billion and assume $760 million in debt, making the merger valued
at $2.5 billion.

The reasoning for the merger is simple: combine Royal Numico's research
and product development pipeline with GNC's manufacturing and marketing
pipeline. Company officials said the union of GNC's distribution and
production brawn with Royal Numico's research brains would produce an
international nutritional Goliath.

"That's the beauty of this," GNC President and Chief Executive William
Watts told Reuters. "It's top line synergies instead of cost cutting. There will
be no layoffs, no reductions."

The move may prompt U.S. pharmaceuticals, who have entered into the
rocketing vitamin and nutritional supplement market but have shunned retail,
to rethink their strategy, said Matthew Patsky, managing director of the
Boston-based investment bank Adams, Harkness & Hill.

"This is the beginning of a heated race for people to get in the race for
franchises," he said. "Watching a major player in Europe has got to heighten
their interest. Maybe the Dutch are seeing something and we're not."

The merger is expected to be completed within five weeks and both boards
have approved the deal. The merger is not expected to face any anti-trust
obstacles, as Numico has no significant presence in the United States,
Watts said.

The companies also said the deal would immediately boost earnings by
about $278.6 million as GNC begins to produce products Numico developed.

With an extensive network of manufacturing and distribution facilities,
Pittsburgh-based GNC has captured 12.9 percent of the $9 billion U.S.
vitamin and nutritional supplement market.

In fiscal 1998, the company reported sales of $1.2 billion.

GNC is recovering from a stock dive during the year that saw the price of its
shares fall from a 52-week high of $32.50 to a low of 9 on Oct. 8, as an surge
of new producers. In March, the company reported fourth-quarter earnings of
$0.31 per share before charges compared with $0.42 per share a year before
and shares again slide to about $10.

Royal Numico, based in Zoetermeer, The Netherlands, has captured 40
percent of the infant nutritional products market in Europe and is the
European leader in clinical nutritional products.

About five years ago, Numico decided it would use the research that came
out of its products developed for its two core businesses for an entrance into
the vitamin and nutritional market -- a market where there is no clear leader.

"That's why we went to the U.S." Albert Eenink, Numico's global director of
research and a member of its executive committee, told Reuters.

Royal Numico's share in the European vitamin and mineral market is about 5
percent and accounted for a small portion of its sales.

Its is developing future products targeted to the athletic and elderly market.

Watts, 46, will remain CEO and president of GNC, and has extended his
2-1/2 year contract an additional year. He also will become part of Numico's
executive committee, a governing board under Numico's president and two
vice presidents. About 90 other GNC senior executives also will be on the
board.

The combined company had a 1998 proforma turnover of about $3 billion and
a workforce of 27,000.

GNC operates 4,203 specialty shops in the United States and about 50 in
the United Kingdom. Its products also are marketed under the name of
PharmAssure, in a deal it half owns with Rite Aid Corp. <RAD.N> The
company also plans to sell its GNC labeled products in its specialty shops
within Rite Aid.

((Ilaina Jonas, New York Newsdesk, 212-859-1610))

COPYRIGHT © 1999 REUTERS LIMITED. ALL RIGHTS RESERVED.